/People

Chris Gibson

InvestorUnicorn founder

Co-founder and Chairman of the Board at Recursion Pharmaceuticals · Operating Partner at Dimension Capital · Portfolio Director, Private Equity at Bridges Fund Management Ltd. · Co-founder and CTO at Kaleidoscope Bio

Salt Lake City, Utah

Writes $5K – $50K checks · typically $25K

FoundedRecursion Pharmaceuticals$2.9BKaleidoscope Bio

Find your path to Chris

498 people in our graph can introduce you to Chris.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Anna Bitton to introduce you to Chris

You →Anna · together at Dimension Capital (2026) →Chris

Ask Jamie Chen to introduce you to Chris

You →Jamie · together at University of Utah →Chris

Ask Sam Okafor to introduce you to Chris

You →Sam · together at Divergence Labs →Chris

Sign up to find every way you can get introduced to Chris

  • Your email: the people you already email who know Chris
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Chris
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Chris Gibson is a Portfolio Director in Bridges' Private Equity team, working with purpose-driven management teams to scale early-growth-stage businesses. Before Bridges he spent nine years as a Director at the Flowerdale Group overseeing its private equity portfolio in Hong Kong and London, and served as CFO of a US paper-crafting brand he helped relaunch, scale and exit. He qualified as a Chartered Accountant with KPMG in South Africa after studying Finance & Accounting at the University of Cape Town.

Contact· self-published, not guessed

Likely emails· guessed from name + firm domain, not firm-published

Invests in

Advanced ManufacturingConsumerE-commerceImpact & Social Good

Co-founder and Chairman of the Board at Recursion Pharmaceuticals

Intro paths

→

In turn, Chris can intro founders to Recursion Pharmaceuticals's investors below.

Co-founders at Recursion Pharmaceuticals

BCBlake C. Borgeson
Blake C. BorgesonExecutive Officer, Director

Co-founder and CTO at Kaleidoscope Bio

Intro paths

→

In turn, Chris can intro founders to Kaleidoscope Bio's investors below.

Co-founders at Kaleidoscope Bio

ET
Ewan TaylorCSO and Co-founder
GP
Geraldine PaulusCo-founder, VP Operations
DYDavid Yen
David YenFounder

Experience

  1. BOXBOXCo-Founder and CEOcurrent2026 — presentNew York, United States
  2. DIMENSIONOperating Partnercurrent2026 — presentSan Francisco Bay Area and New York
  3. PacBioMember Board of Directorscurrent2026 — present
  4. Divergence LabsBoard Membercurrent2026 — present
  5. CellinoBoard Membercurrent2024 — present
  6. The Salt Lake TribuneBoard Membercurrent2024 — present
  7. Project GammaCo-Founder and Managing Directorcurrent2024 — present
  8. RecursionCo-Founder and Chairman2026
  9. RecursionCo-Founder and CEO2013 — 2026Salt Lake City Metropolitan Area
  10. Cure HHTMember Board of Directors2016 — 2020
  11. University of UtahMD/PhD Student2009 — 2013
  12. UTHSCSAMD/PhD Student2005 — 2009

Skills & more

Entrepreneurship14Molecular Biology29Drug Discovery34Cell Culture19Microscopy13Confocal Microscopy11Bioinformatics11Tissue Culture8Medicine7Genetics7Cell Biology12Cell5
+12 moreAssay DevelopmentBiomedical EngineeringLife SciencesBiotechnologyTissue EngineeringBiomaterialsBioengineeringImmunofluorescenceBiomedical DevicesStem CellsCardiovascular BiologyHigh-Throughput Screening

Languages French

From Chris's professional profile.

Investments

Per curated public sources.

Colleagues at Dimension Capital

Network14

▶2 more connections

Alex MorganCeline Passedouet

Investors connected to Chris in public investor directories — a warm-intro map.

Frequently asked questions

Who is Chris Gibson?
Chris Gibson is a Portfolio Director in Bridges' Private Equity team, working with purpose-driven management teams to scale early-growth-stage businesses. Before Bridges he spent nine years as a Director at the Flowerdale Group overseeing its private equity portfolio in Hong Kong and London, and served as CFO of a US paper-crafting brand he helped relaunch, scale and exit. He qualified as a Chartered Accountant with KPMG in South Africa after studying Finance & Accounting at the University of Cape Town.
Where does Chris Gibson work?
Chris Gibson is Co-founder and Chairman of the Board of Recursion Pharmaceuticals and Operating Partner at Dimension Capital and Co-founder and CTO at Kaleidoscope Bio.
What does Chris Gibson invest in?
Chris Gibson invests in Advanced Manufacturing, Consumer, E-commerce, Impact & Social Good.
What check size does Chris Gibson write?
Chris Gibson typically writes checks of $5K – $50K.
What companies did Chris Gibson found?
Chris Gibson founded Recursion Pharmaceuticals, Kaleidoscope Bio.
What companies has Chris Gibson invested in?
Investments tracked here include 64x Bio, A-Alpha Bio, Algen Biotechnologies, Amenities Health, Cellino, Cradle, Dunia Innovation, Enveda Biosciences, Inato, Iterative Health, Juvena Therapeutics, Kaleidoscope, and 15 more.
Where did Chris Gibson go to school?
Chris Gibson studied at University of Utah (Ph.D., Bioengineering); Stanford University Graduate School of Business (IGNITE Certificate, Entrepreneurship/Entrepreneurial Studies); Rice University (Bachelor of Science (B.S.), Bioengineering and Biomedical Engineering).

Founder mafias

Same school

Shared employers